FDA and BRAT Frameworks for Structured Approaches to Benefit-risk Assessment Bennett Levitan, MD-PhD Department of Epidemiology, Janssen Research and Development American Statistical Association and Bayer HealthCare Work - Janssen - Document - PDFSEARCH.IO

First Page	Meta Content
	FDA and BRAT Frameworks for Structured Approaches to Benefit-risk Assessment Bennett Levitan, MD-PhD Department of Epidemiology, Janssen Research and Development American Statistical Association and Bayer HealthCare Work Add to Reading List Document Date: 2013-11-16 12:23:38 Open Document File Size: 2,31 MB Share Result on Facebook Company Janssen R&D / Bayer / / IndustryTerm treatment of various thromboembolic diseases / pharmaceuticals / / MedicalCondition thromboembolic diseases / secondary myelofibrosis / / Organization American Statistical Association / FDA / Department of Epidemiology / / Person Patrick Frey / Bennett Levitan / / Position Driver / / Product Shure E2c Headphone/Headset / / SocialTag Ethics Actuarial science Risk management Pharmaceuticals policy Security Prescription Drug User Fee Act Risk assessment Center for Drug Evaluation and Research Food and Drug Administration Risk

FDA and BRAT Frameworks for Structured Approaches to Benefit-risk Assessment Bennett Levitan, MD-PhD Department of Epidemiology, Janssen Research and Development American Statistical Association and Bayer HealthCare WorkAdd to Reading List